Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on September 24, 2026

2 hours ago

Claris Bio Establishes Corporate Headquarters in San Francisco

Indeterminate GlobeNewswire

2 hours ago

Cronos Hosts 2026 Investor Day

Indeterminate GlobeNewswire

2 hours ago

Stingray and Stellantis Expand TuneIn Access in Future Vehicles

Indeterminate GlobeNewswire

2 hours ago

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Indeterminate GlobeNewswire

2 hours ago

Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma

Indeterminate GlobeNewswire

2 hours ago

Biolinq Shine™ Receives FDA 510(k) Clearance for Over-the-Counter Use

Indeterminate GlobeNewswire

2 hours ago

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

Indeterminate GlobeNewswire

2 hours ago

Precision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund

Indeterminate GlobeNewswire

2 hours ago

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

2 hours ago

Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma

Indeterminate GlobeNewswire

2 hours ago

Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO

Indeterminate GlobeNewswire

2 hours ago

New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)

Indeterminate GlobeNewswire

2 hours ago

Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting

Indeterminate GlobeNewswire

2 hours ago

Sofwave Receives NMPA Approval in Mainland China

Indeterminate GlobeNewswire

3 hours ago

Immuneering to Present at the ESMO Congress 2026

Indeterminate GlobeNewswire

3 hours ago

Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products

Indeterminate GlobeNewswire

3 hours ago

Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October

Indeterminate GlobeNewswire

3 hours ago

Kraig Biocraft Laboratories Reaches Major Scientific Milestone with Completion of Functional and Living Atlas Gene Library

Indeterminate GlobeNewswire

3 hours ago

Coave Therapeutics to Present New Data on Wet AMD Gene Therapy Program at 26th Euretina Congress as it Advances towards the Clinic

Indeterminate GlobeNewswire

3 hours ago

Atavistik Bio Announces Strategic Research Collaboration with Roche to Discover and Develop Novel Allosteric Therapeutics

Indeterminate GlobeNewswire